By Chuck Mikolajczak NEW YORK (Reuters) -U.S. stocks advanced on Wednesday in choppy trading, buoyed as semiconductor stocks rallied late on a report that regulations on artificial intelligence chips would be loosened. For most of the session, stocks bounced around, and trading remained choppy after the Federal Reserve kept U.S. interest rates unchanged in a …
Late chip rally lifts stocks after Fed holds rates steady Read More »
By Marcela Ayres BRASILIA (Reuters) -Brazil’s central bank raised interest rates by 50 basis points on Wednesday in a sixth straight hike that pushed borrowing costs to their highest in nearly 20 years, and left future steps open amid global uncertainties and sticky domestic inflation. The bank’s monetary policy committee, known as Copom, raised the …
Brazil central bank hikes rates to near 20-year high, leaves next steps open Read More »
By Karen Freifeld and Arsheeya Bajwa (Reuters) -U.S. President Donald Trump’s administration plans to rescind and modify a Biden-era rule that curbed the export of sophisticated artificial-intelligence chips, a spokeswoman for the Department of Commerce said on Wednesday. The regulation was aimed at further restricting AI chip and technology exports, dividing up the world to …
Trump administration to rescind and replace Biden-era global AI chip export curbs Read More »
(Reuters) -Nutrien fell short of Wall Street expectations for first-quarter profit on Wednesday, as the top potash producer was impacted by lower prices and higher energy costs. Trade tensions between the United States and China following U.S. President Donald Trump’s tariffs have led to volatility in crop prices over the past few months, prompting farmers …
Top potash producer Nutrien misses first-quarter profit estimates on lower prices Read More »
By Howard Schneider, Ann Saphir WASHINGTON (Reuters) -The Federal Reserve held interest rates steady on Wednesday but said the risks of higher inflation and unemployment had risen, further clouding the U.S. economic outlook as its policymakers grapple with the impact of President Donald Trump’s tariffs. At this point, Fed Chair Jerome Powell said, it isn’t …
Fed sees rising risks to economy as it leaves rates unchanged Read More »
By David Shepardson WASHINGTON (Reuters) -California and 15 other states sued the Trump administration on Wednesday, saying the federal government was illegally withholding billions of dollars awarded to states for building electric-vehicle charging stations. The U.S. Transportation Department in February suspended the EV charging program and rescinded approval of state plans pending a review. Senate …
US states sue over Trump freeze on funds for electric-vehicle charging stations Read More »
By Ernest Scheyder (Reuters) -A U.S. federal judge said he will rule by May 14 on whether to block the Trump administration from transferring Arizona land to Rio Tinto and BHP to build a major copper mine opposed by Native Americans. The long-running and complex legal case pits the religious rights of Arizona’s San Carlos …
US judge to rule by May 14 on Rio Tinto copper project opposed by Native Americans Read More »
By Sheila Dang HOUSTON (Reuters) -Exxon Mobil has signed a long-term agreement to supply 250,000 metric tons of low-carbon ammonia annually to Japanese trading house Marubeni, the U.S. oil producer said on Wednesday, representing Exxon’s first signed customer agreement for its planned hydrogen facility in Baytown, Texas. The agreement is a step forward in Exxon’s …
Exxon agrees to supply Japan’s Marubeni with low-carbon ammonia Read More »
(Reuters) -U.S. agrichemicals firm Corteva beat Wall Street expectations for first-quarter profit on Wednesday, helped by higher prices for its seeds. The results come as the agrichemical industry braces itself against a potential fallout from U.S. President Donald Trump’s trade policy. Corteva said it continues to expect current-year net sales of $17.2 billion to $17.6 …
Corteva beats first-quarter profit estimates on higher seed pricing Read More »
(Reuters) -OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator’s use of AI, technology news platform Wired reported on Wednesday, citing sources with knowledge of the meetings. Sources close to the project say a small team from OpenAI has met with the FDA and two associates of Elon …
OpenAI and US FDA hold talks about using AI in drug evaluation, Wired reports Read More »
